Article Information
History
- October 15, 2021.
Article Versions
- Version 1 (September 22, 2021 - 10:32).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Yanmeng Feng1,§,
- Yifan Zhang2,3,4,§,
- Zhangyufan He2,4,§,
- Haojie Huang5,
- Xiangxiang Tian2,3,4,
- Gang Wang4,
- Daihong Chen4,
- Yanqin Ren2,
- Liqiu Jia2,
- Wanhai Wang3,
- Jing Wu2,
- Lingyun Shao2,
- Wenhong Zhang2,6,7,8,
- Heng Tang1,# and
- Yanmin Wan2,7,9,#
- 1Hubei Provincial Center for Disease Control and Prevention, Wuhan 430065, China
- 2Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai 200040, China
- 3Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, Key Laboratory of Laboratory Medicine of Henan Province, Zhengzhou 450052, China
- 4Department of laboratory medicine, Shanghai Public Health Clinical Center, Shanghai 201508, China
- 5Wuhan Pioneer Social Work Service Center, Wuhan 430071, China
- 6Key Laboratory of Medical Molecular Virology (MOE/MOH) and Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai 200032, China
- 7State Key Laboratory of Genetic Engineering, School of Life Science, Fudan University, Shanghai 200438, China
- 8National Clinical Research Centre for Aging & Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China
- 9Department of radiology, Shanghai Public Health Clinical Center, Shanghai 201508, China
- ↵#Correspondence should be addressed to: Heng Tang, 867555881{at}qq.com; Yanmin Wan, yanmin_wan{at}fudan.edu.cn
↵§ These authors contribute equally to this work.
Posted October 15, 2021.
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine in people living with HIV-1
